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There was no recurrence of these lesions
during a period of five years.
Introduction
Abscesses and sinuses (besides spinal cord
involvement) are common complications of
spinal tuberculosis. Abscesses can be either
clinically evident or only radiographically visible,
and the former may co-exist with sinuses.1-9 In
Madras, a controlled clinical study was
undertaken in patients with spinal tuberculosis to
compare 6 or 9 months of ambulatory out-patient
chemotherapy (Isoniazid and Rifampicin daily)
with radical surgery plus 6 months of the same
chemotherapy.10 This report presents the
prevalence, incidence and resolution of sinuses
and/or clinicallyevident abscesses and
mediastinal abscesses during a period of 5 years
in these patients.
Material and Methods
Eligibility criteria : Patients with clinically and
radiographically active spinal tuberculosis,
involving any vertebral body from the first
thoracic to first sacral inclusive, were eligible for
admission to the study provided they did not have
paralysis (of lower limbs) severe enough to
prevent them from walking across a room (about
6 metres), and had not received previous anti-
tuberculosis chemotherapy for 12 months or
more. Patients wereadmitted from 6
participating hospitals in Madras.
Pre-treatment investigations : The
investigations included : (a) complete clinical
(including neurological) examination, (b) antero-
posterior (AP) and lateral radiographs of the
whole spine, (c) examination by culture of 2
specimens of pus from any abscess or sinus, if
pres nt, and (d) sensitivity tests to Isoniazid and
Rifampicin of positive cultures. Details of other
investigations have been given in an earlier
report.10
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Allocation of treatment : Patients were
allocated at random to one of the following 3
ser ies .
1. Rad 6 : Radical anterior resection with bone
grafting plus Isoniazid and Rifampicin in one
dose daily for 6 months.
2. Amb 6 :Ambulatory treatment with
Isoniazid and Rifampicin in one dose daily
for 6 months.
3. Amb 9 :Ambulatory treatment with
Isoniazid and Rifampicin in one dose daily
for 9 months.
examination by smear and culture of pus from
a y sinus or abscess.
Bacteriological examination : Bacteriological
examinations (smear, culture, sensitivity and
identification tests) were undertaken by standard
techniques11 using additional media for culture of
pus specimens.12-14 The following definitions of
drug resistance were used:
Isoniazid : growth of 20 colonies or more on
0.2 mg/l or a higher concentration.
Rifampicin : growth of 20 colonies or more on
64 mg/l or a higher concentration.
The dosages were based on patients’ body-
weights, and were 5-7 mg/kg body weight for
Isoniazid and 10-15 mg/kg for Rifampicin. In the
Rad 6 series, surgery was undertaken within one
month of the start of chemotherapy.
Administration of anti-tuberculosis drugs : For
all in-patients and for outpatients aged less than
5 years, every dose of drugs was administered
under the direct supervision of a staff member.
Out-patients aged 5 years or more attended the
clinic twice-weekly and at each attendance, the
dose for that day was administered under direct
supervision, and the medicament (2 or 3 doses)
supplied for self-administration (of
administration by the parent) for the days until
the next visit.
Results
Study population : In all, 304 (10 Rad 6, 101
Amb 6, 103 Amb 9) patients were admitted to
the study. For various reasons, 51 patients were
excluded from analysis. The details of exclusions
for 44 patients during the first 3 years were given
in a previous report;10 during the 3-5 year period
of follow-up, 7 other patients (1 Rad 6, 2 Amb 6, 4
Amb 9) were excluded-2 were lost to follow-up
and 5 died of non-tuberculous causes. After these
exclu ions, there remained 253 patients (84 Rad
6, 81 Amb 6, 88 Amb 9) in the analysis.
Assessment of progress : Progress was assessed
monthly until the end of chemotherapy, then
every 3 months until 30 months, then at 6-
monthly intervals until 5 years. The assessments
included : (1) clinical (including neurological)
examination, (2) AP and lateral radiographs of
the vertebrae involved, and (3) bacteriological
Condition on admission : The patients who
had sinuses and/or clinically evident abscesses on
admission and the patients who did not have
sinuses and/or abscesses on admission were
broadly similar with respect to sex, radiographic
activi y, vertebral body loss and number of
vertebrae involved. but of the 63 patients aged 9
years or less, 5 (8%) had abscess and/or sinus, as
compared with 44 (23%) with abscess/sinus
Table 1. Prevalence and resolution of sinuses and/or clinically evident abscesses
Treatment Total No. of patients
s e r i e s  patients with sinuses and/ Resolution
or clinically (by months)
evident abscesses
initially
No. % 1 2 3 6 9 12 60
Rad 6 84 16 19 7 14 14 15 16 16 16
Amb 6 81 20 25 3 7 13 17 20 20 20
Amb 9 88 13 15 1 4 7 11 12 12 13
Total 253 49 19 11 25 34 43 48 48 49
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among the 190 patients aged more than 9 years
(p = 0.01).
Prevalence of sinuses and/or clinically evident,
abscesses (present on admission) : The
proportions of patients with sinuses and/or
clinically evident abscesses on admission (Figures
1 & 2) were similar in the three series, being 16
(19%) of the 84 Rad 6, 20 (25%) of the 81 Amb 6
and 13 (15%) of the 88 Amb 9 patients (Table 1).
In all, 49 (19%) of 253 patients had this lesion on
admission; 38 (11 Rad 6, 17 Amb 6, 10 Amb 9)
had clinically evident abscess only, 6 (1 Rad 6, 2
Amb 6, 3 Amb 9) had sinus only and 5 (4 Rad 6, 1
Amb 6) had both.
Resolution of sinuses and/or clinically evident
abscesses :The resolution of sinuses and/or
clinically evident abscesses is shown in Table 1.
An abscess or sinus has been considered as
resolved only if this assessment was made at two
or more consecutive scheduled examinations. The
speed of resolution was similar for abscesses and
sinuses and, therefore, the results have been
amalgamated.
The sinuses and/or clinically evident
abscesses had resolved by the first month in 7 of
the 16 Rad 6 patients, by 2 months in a total of 14
and by 6 months in 15. In contrast, in the Amb 6
and Amb 9 series combined, resolution occurred
in 4 of the 33 patients by 1 month, 11 by 2
mo ths, 29 by the end of chemotherapy and in a
Fig. 1. External abscess in the right inguinal region
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Fig. 2. A sinogram showing the sinus-tract from the sinus to the abscess
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Table 2. Incidence and resolution of sinuses an&or clinically evident abscesses
Treatment
series
Total 
patients
at risk
No. of
patients
with sinuses
and/or
clinically
evident
abscesses
appearing
during treatment
No. %
Onset Resolution
(months) (months)
1-6/9* 7/10- 1-6/9* 7/10-
60** 60**
Rad 6 68 5 7 5 0 4 1
Amb 6 61 12 20 9 3 7 5
Amb 9 75 15 20 15 0 12 3
Total 204 32 16 29 3 23 9
* Treatment phase
** Follow-up phase
total of 32 patients by 9 months. In the remaining
patient (Amb 9), the abscess had resolved by 3
months; 2 sinuses were evident at 9 months but
both had resolved by 21 months. The resolution
was faster in the Rad series than in the 2
ambulatoryseries, the difference being
statistically significant (p = 0.04 at 1 month,
p < 0.001 at 2 months).
None had additional chemotherapy or
surgery. Further, there was no recurrence of the
lesions during the 5-year period.
In 9 of the 16 Rad 6 series patients, the sinuses
and/or clinically evident abscesses resolved
without aspiration or incision compared with 8 of
the 33 patients in the two ambulatory series. In
the other 7 patients in the Rad series, 1 or more
aspirations of abscesses were performed. In the
ambulatory series, 20 patients (11 Amb 6, 9 Amb
9) had 1 or more aspirations of abscesses and in
the remaining 5 (3 Amb 6, 2 Amb 9) the
abscesses were incised.
Incidence of sinuses and/or clinically evident
abscesses observed after the start of chemotherapy:
The incidence and resolution of sinuses and/or
clinically evident abscesses observed for the first
time after start of treatment is presented in Table
2. Of 204 patients (68 Rad 6, 61 Amb 6, 75 Amb
9) who did not have a sinus and/or clinically
evident abscess on admission, 32 (5 Rad 6, 12
Amb 6, 15 Amb 9; 16%) developed the lesions, 29
(5 Rad 6, 9 Amb 6, 15 Amb 9) during the
reatment phase and 3 (all Amb 6) in the follow-
up phase. The incidence was 7% of 68 in the Rad
6, and 20% of 136 in the two ambulatory series,
the difference being significant (p = 0.03). Of
these 32 patients, 25 (3 Rad 6, 11 Amb 6, 11 Amb
9) developed clinically evident abscesses alone, 3
(2 Rad 6, 1 Amb 6) had sinuses alone and 4 (all
Amb 9) developed both. The lesions had resolved
in 23 (4 Rad 6, 7 Amb 6, 12 Amb 9) by the end of
treatment and in the remaining 9 (1 Rad 6, 5
Amb 6, 3 Amb 9) by 60 months.
In the vast majority, namely 28 (4 Rad 6, 9
Amb 6, 15 Amb 9) patients, the lesions had
resolv d without additional surgery or
chemotherapy and the remaining 4 needed
additional chemotherapy and/or surgery (For
details, please see pp. 156-157).
Of the 32 with incidence, aspiration was done
in 24 (2 Rad 6, 8 Amb 6, 14 Amb 9), incision in 1
(Rad 6) and both in 1 (Amb 9). No recurrence of
the lesions was observed during the 5-year
peri d.
Prevalence, incidence and resolution of sinuses
and/or clinically evident abscesses : Th  overall
prevalence, incidence and resolution of sinuses
and/or clinically evident abscesses from
admission till 60 months is presented in Table 3.
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Table 3. Prevalence, incidence and resolution of sinuses and/or clinically evident abscesses
Treatment Total           No. of Resolution after additional
series patients patients with Resolution
sinuses and/or Surgery Chemo- Surgery
clinically. on allocated only therapy       & chemo-
evident treatment only therapy
abscesses
during5 years
No. % No. % of
(a) (a)
Rad 6 84 21 25 20 95 1 0 0
Amb 6 81 32 40 29 91 0 2 1
Amb 9 88 28 32 28 100 0 0 0
Total 253 81 32 77 95 1 2 1
Of the 253 patients, 81 (32%) patients (21 Rad 6,
32 Amb 6, 28 Amb 9) had sinuses and/or
clinically evident abscesses and the lesions
resolved on the allocated treatment in 20 of the
21 Rad 6 patients, in 29 of the 32 Amb 6 and in
all 28 of the Amb 9 patients, that is, in a total of
77 (95%) of the 81 patients. In the remaining 4
patients, one (Rad 6) developed persistent post-
operative sinus at the site of surgery and the graft
was removed in the 33rd month; the sinus was
observed last at the 42nd month. One patient
(Amb 6) developed an abscess during treatment
which persisted till the end of treatment;
additional chemotherapy was given and the
abscess resolved by 9 months. The other 2
patients (both Amb 6) developed abscesses
during follow-up; both had additional
chemotherapy - one for clinically active disease at
the end of treatment in whom the abscess
resolved by 18 months, and the other for
persisting paraparesis for whom excision of a
diseased rib also was done in the 10th month and
the abscess subsided by 12 months.
   Sinuses and/or clinically evident abscesses on
admission in relation to the level of the spinal
lesions : The distribution of the prevalence of
sinuses and/or clinically evident abscesses in
relation to the initial level of vertebral
involvement is shown in Table 4. Of the 93
patients who had a spinal lesion in the thoracic
region, 11 (12%) had an abscess or sinus; the
corresponding figures were 7 (21%) in the
thoraco-lumbar region and 31 (25%) in the
lumbar region (26 lumbar, 5 lumbo-sacral).
Thus, the prevalence of abscess and/or sinus was
significantly more in patients with lumbar or
lumbo-sacral lesions (p = 0.05).
Mediastinal abscess shadows on admission
without sinuses and/or clinically evident abscesses
at any time : The disappearance of mediastinal
abscess shadows radiologically evident on
admis ion, which were never manifest externally,
was s udied by an independent assessor. The
llocated regimens of these patients had not been
Table 4. Prevalence of sinuses and/or clinically
evident abscesses in relation to the initial
level of the spinal lesion
Initial
level of
spinal
lesion
Thoracic
Thoraco-
lumbar
Lumbar
Lumbo-
sacral
Total Patients with
patients sinuses and/or
clinically evident
abscesses
No. %
93 11 12
34 7 21
109 26
17 5
25
Total 253 49 19
TREATMENT OF TB SPINE 157
Table 5. Prevalence of mediastinal abscesses without sinus and/or clinically evident abscess at any time,
and their resolution
Treatment Total
series pts.*
Patients      
with             
mediastinal 1
abscess
2
Resolution by (months)
3 6/9 12 18 24 60 Not
resolved
Rad 6 34 21 8 13 13 15 19 20 21 21 0
Amb 6 31 21 1 6 6 9 16 17 19 21 0
Amb 9 35 24 0 5 5 15 19 20 21 22 2
Total No. 100** 66 9 24 24 39 54 57 61 64 2
% 100 66 14+ 36 36  59 82 86 92 97 3
* Excluding patients with lumbar or lumbo-sacral lesions
** Excluding 27 patients with sinuses and/or clinically evident abscesses at any time
+ This and subsequent percentages are based on the total patients with mediastinal abscess initially.
modified by surgery or additional chemotherapy
based on the radiographic findings. A total of 66
(66%) (21 Rad 6, 21 Amb 6, 24 Amb 9) patients
had a radiographically visible mediastinal abscess
on admission (Table 5). Considering the 21 Rad
6 patients, the mediastinal abscess disappeared
by 1 month in 8, by 2 months in 13, by 6 months
in 15, by 18 months in 20 and by 24 months in all.
In the 45 (21 Amb 6, 24 Amb 9) ambulatory
patients, the lesions were not seen by 1 month in
1, by 2 months in 11, by 6/9 months in 24, by 18
months in 37, by 24 months in 40 and by 60
months in 43 patients. Of the remaining 2
patients (both Amb 9), one had a persistent
abscess shadow which had calcified; the other
had a persistent abscess shadow, even though he
had decompression surgery for worsening of
paraparesis in the 2nd month. The mediastinal
abscesses had disappeared more rapidly in the
Rad 6 series than in the combined Amb
series, the difference being statistically significant
(p < 0.001 at 1 month; p < 0.01 at 2 and 3
months). In all, the mediastinal abscess
disappeared during the treatment phase in 39 (15
Rad 6, 9 Amb 6, 15 Amb 9) patients, during the
follow-up period without any intervention in 25
(6 Rad 6, 12 Amb 6, 7 Amb 9) patients and did
not resolve in 2 Amb 9 patients even by 60
months.
No information is available on the incidence
of mediastinal abscess.
Bacteriology of pus from abscesses and sinuses
(both aspirated and at surgery) : Of the 49 (16
Rad 6, 20 Amb 6, 13 Amb 9) patients with.
sinu es and/or clinically evident abscesses on
admission, aspiration or incision was done in 32
(7 Rad 6, 14 Amb 6, 11 Amb 9) patients; the
specimens were examined bacteriologically and
the culture was positive for M. Tuberculosis in 18
(56%) patients. Pus was collected during surgery
fr m 13 Rad 6 patients, of which 4 were positive
by culture including one from a patient for whom
the aspirated pus also yielded M. tuberculosis on
culture. These 13 patients included the 7 (Rad 6)
who had aspiration also. In the remaining 3 Rad
6) patients, pus was neither aspirated nor collected
during surgery. Thus, bacteriological
examination of the pus was undertaken in 38 (13
Rad 6, 14 Amb 6, 11 Amb 9) of the 49 patients
nd culture was positive in 21 (55% - 7 Rad 6, 8
Amb 6, 6 Amb 9) patients; all were sensitive to
Rifampicin and Isoniazid.
Prevalence, incidence and resolution of sinuses
/or clinically evident abscesses in patients who
w re excluded from the analysis : Among 51
patients excluded from the analysis, 19 were
either found to have no evidence of active
tuberculosis or were withdrawn from the study as
unsuitable for surgery; 1 patient who had an
abscess on admission died 12 days after starting
treatment. Of the remaining 31 (6 Rad 6, 13 Amb
6, 12 Amb 9) patients 8 (2 Rad 6, 3 Amb 6, 3
Amb 9) had a sinus and/or clinically evident
ab cess on admission; 6 had an abscess alone and
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2 had both abscess and sinus. The sinus and/or
clinically evident abscess resolved by the end of
chemotherapy in six (2 in each series) and by 21
months in the other 2 (1 Amb 6, 1 Amb 9)
patients. There was no recurrence of the lesions
during the 5-year period, and none developed an
abscess or sinus during treatment or in the
follow-up phase.
Discussion
Sinuses and/or clinically evident abscesses
and mediastinal abscess (besides spinal cord
involvement). are common complications of
spinal tuberculosis. The present report gives 5-
year findings of these two complications,
encountered during an investigation of short-
course chemotherapy in the treatment of spinal
tuberculosis.
Unlike in pulmonary tuberculosis,
bacteriological confirmation of tuberculosis in
extra-pulmonary forms, which are paucibacillary,
is difficult. However, with the introduction of
selective and multiple media, the culture
positivity rates are high.12-14 In the present study,
pus obtained from sinus and/or clinically evident
abscess present on admission, by aspiration or
incision, was examined in 32, of which 18 (56%)
were culture positive. This result compares
favourably with the culture positivity rate of 40%
obtained by examination of aspirated pus in
British Medical Research Council studies.15,16
The prevalence of sinus and/or clinically
evident abscess was 49 (19%) of 253 patients in
this study. This is similar to the prevalence of
22% observed among 587 patients in Masan,
Pusan, Bulawayo and Hong Kong.1-4,9
The incidence of sinus and/or clinically
evident abscess was not influenced by the kind of
chemotherapy given; it was 27 (20%) of 136
patients receiving 6 or 9 months of daily Isoniazid
plus Rifampicin (present study) and 59 (22%) of
273 patients treated with 18 months of daily
Isoniazid plus PAS, with or without an initial
Streptomycin supplement1-3 i  Masan, Pusan and
Bulawayo. Considering the role of surgery, in the
present study the incidence was 5 (7%) of 68 in
the Rad 6 series treated with 6 months of daily
Isoniazid and Rifampicin plus modified Hong
Kong surgery and 9% of 44 Hong Kong patients
treated with a regiment similar to the present Rad
6, excepting that the duration of chemotherapy
was either 6 or 9 months,9 as compared with 27
(20%) of 136 in the Amb 6 and Amb 9 series
combined in the present study(p = 0.03). A
similar difference has been reported in studies
with 18 months of daily Isoniazid plus PAS; the
i cid nce was only 2% of 142 patients who had
chemotherapy plus surgery (i.e. debridement or
radical operation) as compared with 22% of 273
patients who had chemotherapy alone.1-4 These
findings indicate that surgery substantially
reduced the incidence of sinuses and/or clinically
evident abscesses.
The speed of resolution of sinuses and
clinically evident abscesses with short-course or.
standard chemotherapy, with or without
addi ional surgery, is also of interest. Of 86
patients treated with 18 months of daily Isoniazid
plus PAS, the lesions resolved in 29 (34%) by 3
months, 46 (53%) by 6 months and 71 (83%) by
12 months.1-3 In the present study, of 33 patients
treated with 6 or 9 months of daily Isoniazid plus
Rifampicin, the corresponding figures were 20
(61%), 28 (85%) and 32 (97%), respectively.
This finding suggests that the resolution was
faster in those treated with short-course
chemotherapy (SCC) than in those treated with
standard chemotherapy. Considering the 23
tients (Madras : 16; Hong Kong : 7) treated
with radical surgery plusshort-course
chemotherapy (6 or 9 months of daily Isoniazid
plus Rifampicin), the lesions resolved in 20
(87%) by 3 months and in 21 (91%) by 6
months.9 These proportions are higher than in
those treated with ambulatory short-course
chemotherapy, suggesting that surgery enhanced
the speed of resolution further. In the patients
treated with surgery (debridement or radical
operation) plus 18 months of daily Isoniazid and
PAS, the lesions resolved in 25 (71%) by 3
months, in 29 (83%) by 6 months and in 33
(94%)) by 12 months3,4 these proportions are
higher than in those treated with 18 months of
daily Isoniazid plus PAS without surgery.1-3 Thus
the speed of resolution was greater when surgery
was undertaken in addition to chemotherapy.
By 5 years, the lesions had resolved in all 81
(100%) patients treated with short-course
chemotherapy of 6 or 9 months’ duration with or
without surgery (present study), as compared to
117 (92%) of 127 patients who were treated with
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18 months of chemotherapy alone and in all 67
patients who were treated with surgery in
addition to 18 months of chemotherapy.1-4
Considering the disappearance of
radiographically visible mediastinal abscesses
present on admission, at the end of chemotherapy,
that is at 6 or 9 months in the present study and the
second study in Hong Kong,9 the abscesses had
disappeared in 15 (71%) of 21 patients in the Rad
series and in 24 (53%) of 45 patients in the
combined Amb series in Madras and in 8 or 9 of
12 patients treated with radical surgery plus short-
course chemotherapy in Hong Kong. This finding
suggests that the disappearance of the abscesses
     was faster in patients treated with radical surgery
in addition to short-course chemotherapy. In
patients treated with 18 months of Isoniazid plus
PAS (standard chemotherapy), the abscesses had
disappeared in 69 (83%) of 83 patients at the end
of treatment.1-3 The corresponding figures for
patients treated with additional debridement were
26 (81%)) of 323 and with additional radical
surgery, 19 (86%) of 224. This similarity suggests
that surgery (debridement or radical) did not
enhance the rate of resolution of mediastinal
abscesses in patients treated with PAS and
Isoniazid daily for 18 months. By 18 months, the
lesions had disappeared in 95% in short-course
chemotherapy series even though they did not
receive any anti-tuberculosis drugs beyond 6 or 9
months. These proportions are similar to the 81-
86% observed at the end of 18 months of
Isoniazid plus PAS, with or without surgery (see
above). Unlike the resolution of sinuses and/or
clinically evident abscesses, the radiological
disappearance of mediastinal lesion was not
influenced by the kind of chemotherapy given.
It is concluded that clinical abscess/sinus and
mediastinal abscess do not pose any special
problems in management and respond well to
short-course chemotherapy consisting of daily
Isoniazid plus Rifampicin of 6 or 9 months
duration. The resolution of sinuses and clinically
evident abscesses was faster with short-course
chemotherapy than with standard chemotherapy.
When surgery was undertaken in addition, the
resolution was faster irrespective of the type of
chemotherapy. The incidence of sinuses and/or
clinically evident abscesses was also significantly
less in patients who underwent surgery. The
resolution of mediastinal abscesses was also faster
in the surgical series. These findings are different
from the conclusion reported in another paper, on
5-year findings inpatients with spinal
tuberculosis17 that, ambulatory chemotherapy
with daily Isoniazid and Rifampicin for 6 or 9
months was highly effective in spinal tuberculosis
 radical surgery did not enhance the efficacy
of the 6-months regimen. However, by 5 years,
the resolution of sinuses and/or clinically evident
or mediastinal abscesses. was equal in both
ambulatory and surgical series.
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